More than 330 provider organizations signed letters this week urging the White House and Congress to extend a pandemic-era telehealth prescribing flexibility. Failure to extend this policy would cause millions of Americans to lose access to treatment, they argued.
These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes. Learn More.
In just seven days, join us at Pegasus Park in Dallas, Texas for an event that brings together the brightest minds in healthcare. Get ready to transform your perspective and connect with professionals driving the next wave of digital health.
We'll see you in just one-week, next Wednesday, September 18 at INVEST Digital Health 2024!
Securities regulators say the role of Ipsen employee Dishant Gupta made him privy to details of the Epizyme acquisition. Gupta allegedly accumulated Epizyme shares while the deal was negotiated, then sold all of them hours after the transaction was announced.
A direct-to-patient model for observational research will ease the participation burden, better incorporate the patient voice, and empower individuals to take control of their health – all while meeting the growing demands for robust evidence in developing new drugs and therapeutics.
By surfacing conversational, behavioral, and environmental insights at the point of care — and enabling data-driven operational decisions — AI has the power to transform individual patient experiences and drive systemic improvements in care quality and efficiency.
In this episode, we're joined by Carolee Lee, CEO and founder of Women's Health Access Matters (WHAM), and Ash Shehata, KPMG U.S. sector leader for healthcare. The two discuss WHAM and KPMG's new partnership that aims to advance women's health research and investment.
No comments